Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11766476
Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines
granted -
US 11766487
Treatments for retinal disease
granted -
US 11767330
Citrate salt, pharmaceutical compositions, and methods of making and using the same
granted -
US 11766032
Genetically modified non-human animals expressing human EPO
granted -
US 11767358
Human antibodies to Bet v 1 and methods of use thereof
granted -
US 11767367
Monoclonal antibody neo-201 for the treatment of human carcinomas
granted -
US 11767526
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11767355
Methods for modulating an immune response
granted -
US 11766432
Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same
granted -
US 11766403
Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders
granted -
US 11766558
Biomedical electrode with anti-microbial properties
granted -
US 11767500
Systems for producing cellular immunotherapeutics and methods of use thereof
granted -
US 11766402
Methods for production of MSC-derived exosomes
granted -
US 11767303
Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections
granted -
US 11769597
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
granted -
US 11767325
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 11767321
5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases
granted -
US 11766408
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11766489
Adeno-associated virus variant capsids and use for inhibiting angiogenesis
granted -
US 11759461
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 11760858
Dendritic macroporous hydrogels prepared by crystal templating
granted -
US 11759531
Gene therapy vectors for treating heart disease
granted -
US 11760799
Leptin antibodies
granted -
US 11760795
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.